GTBP GT BIOPHARMA INC Delisting Actions 8-K Filing 2024 - Nasdaq Compliance GT Biopharma, Inc. was notified by Nasdaq that its stockholders' equity has fallen below the required $2,500,000 for continued listing, but it can submit a plan to regain compliance by January 6, 2025.Get access to all SEC 8-K filings of the GT BIOPHARMA INC